177 related articles for article (PubMed ID: 16649834)
21. Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates.
Shvartzman Y; Krivoy A; Valevski A; Gur S; Weizman A; Hochman E
Eur Neuropsychopharmacol; 2018 Mar; 28(3):353-360. PubMed ID: 29449055
[TBL] [Abstract][Full Text] [Related]
22. Rapid clozapine titration in treatment-refractory bipolar disorder.
Ifteni P; Correll CU; Nielsen J; Burtea V; Kane JM; Manu P
J Affect Disord; 2014 Sep; 166():168-72. PubMed ID: 25012427
[TBL] [Abstract][Full Text] [Related]
23. Clozapine in adolescent inpatients with acute mania.
Masi G; Mucci M; Millepiedi S
J Child Adolesc Psychopharmacol; 2002; 12(2):93-9. PubMed ID: 12188978
[TBL] [Abstract][Full Text] [Related]
24. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study.
Altamura AC; Buoli M; Caldiroli A; Caron L; Cumerlato Melter C; Dobrea C; Cigliobianco M; Zanelli Quarantini F
J Affect Disord; 2015 Aug; 182():70-5. PubMed ID: 25978716
[TBL] [Abstract][Full Text] [Related]
25. Response to clozapine in acute mania is more rapid than that of chlorpromazine.
Barbini B; Scherillo P; Benedetti F; Crespi G; Colombo C; Smeraldi E
Int Clin Psychopharmacol; 1997 Mar; 12(2):109-12. PubMed ID: 9219046
[TBL] [Abstract][Full Text] [Related]
26. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
Vieta E; Calabrese JR; Hennen J; Colom F; Martínez-Arán A; Sánchez-Moreno J; Yatham LN; Tohen M; Baldessarini RJ
J Clin Psychiatry; 2004 Oct; 65(10):1420-8. PubMed ID: 15491248
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
28. Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic.
Patel NC; Crismon ML; Pondrom M
J Behav Health Serv Res; 2005; 32(4):438-45. PubMed ID: 16215452
[TBL] [Abstract][Full Text] [Related]
29. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Perlis RH; Ostacher MJ; Patel JK; Marangell LB; Zhang H; Wisniewski SR; Ketter TA; Miklowitz DJ; Otto MW; Gyulai L; Reilly-Harrington NA; Nierenberg AA; Sachs GS; Thase ME
Am J Psychiatry; 2006 Feb; 163(2):217-24. PubMed ID: 16449474
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
31. Clozapine in severe mood disorders.
Zarate CA; Tohen M; Baldessarini RJ
J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
[TBL] [Abstract][Full Text] [Related]
32. Comorbid personality disorders in manic bipolar I disorder patients is associated with increased use of long-acting injectable antipsychotic treatment and higher rates of rehospitalization.
Goren Y; Krivoy A; Gur S; Valevski A; Weizman A; Hochman E
Int Clin Psychopharmacol; 2020 Mar; 35(2):74-80. PubMed ID: 31764217
[TBL] [Abstract][Full Text] [Related]
33. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.
Vieta E; Nieto E; Autet A; Rosa AR; Goikolea JM; Cruz N; Bonet P
World J Biol Psychiatry; 2008; 9(3):219-24. PubMed ID: 18609430
[TBL] [Abstract][Full Text] [Related]
34. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
Ciapparelli A; Dell'Osso L; Pini S; Chiavacci MC; Fenzi M; Cassano GB
J Clin Psychiatry; 2000 May; 61(5):329-34. PubMed ID: 10847306
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study.
Chan HW; Huang CY; Feng WJ; Yen YC
J Affect Disord; 2016 Nov; 205():360-364. PubMed ID: 27568173
[TBL] [Abstract][Full Text] [Related]
36. Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder.
Chen CK; Shiah IS; Yeh CB; Mao WC; Chang CC
Clin Neuropharmacol; 2005; 28(3):136-8. PubMed ID: 15965313
[TBL] [Abstract][Full Text] [Related]
37. Clozapine in treatment-refractory mood disorders.
Kimmel SE; Calabrese JR; Woyshville MJ; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():91-3. PubMed ID: 7961583
[TBL] [Abstract][Full Text] [Related]
38. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
39. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania.
Suppes T; Ozcan ME; Carmody T
Bipolar Disord; 2004 Aug; 6(4):329-32. PubMed ID: 15225152
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
